AstraZeneca to manufacture cancer killer in Singapore

By : Xinhua

Date: 20 May 2024 10:22am WAT

Follow Us on Google Discover
000_1X327D

(FILES) In this file photo taken on July 21, 2020 a general view is pictured of the offices of British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca PLC in Macclesfield, Cheshire. Pharmaceutical company AstraZeneca said on September 8, 2020 that it had "voluntarily paused" a randomized clinical trial of its coronavirus vaccine in what it called a routine action after a volunteer developed an unexplained illness. Paul ELLIS / AFP

(FILES) In this file photo taken on July 21, 2020 a general view is pictured of the offices of British-Swedish multinational pharmaceutical and biopharmaceutical company AstraZeneca PLC in Macclesfield, Cheshire. Pharmaceutical company AstraZeneca said on September 8, 2020 that it had "voluntarily paused" a randomized clinical trial of its coronavirus vaccine in what it called a routine action after a volunteer developed an unexplained illness. Paul ELLIS / AFP

Paul ELLIS / AFP

AstraZeneca says it will invest 1.5 billion U.S. dollars in building a manufacturing facility in Singapore for antibody drug conjugates (ADCs).

The biopharmaceutical giant announced on Monday.
[ad]
AstraZeneca aimed to start designing and construction of the manufacturing facility by the end of this year, with targeted operational readiness from 2029.

According to the company ADCs are next-generation treatments that deliver highly potent cancer-killing agents directly to cancer cells through a targeted antibody.

download guardian mobile app

Tags:

Join Our Channels

Taboola Recommendation Widget